Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control.

Whittall T, Peters B, Rahman D, Kingsley CI, Vaughan R, Lehner T.

Clin Exp Immunol. 2011 Nov;166(2):208-17. doi: 10.1111/j.1365-2249.2011.04463.x.

2.

Transplantation tolerance: lessons from experimental rodent models.

Kingsley CI, Nadig SN, Wood KJ.

Transpl Int. 2007 Oct;20(10):828-41. Epub 2007 Aug 17. Review.

3.

CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.

Steger U, Kingsley CI, Karim M, Bushell AR, Wood KJ.

Transplantation. 2006 Nov 15;82(9):1202-9.

PMID:
17102772
4.

The ICOS molecule plays a crucial role in the development of mucosal tolerance.

Miyamoto K, Kingsley CI, Zhang X, Jabs C, Izikson L, Sobel RA, Weiner HL, Kuchroo VK, Sharpe AH.

J Immunol. 2005 Dec 1;175(11):7341-7.

5.

IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo.

Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ.

J Exp Med. 2005 Jun 20;201(12):1925-35.

6.

Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.

Karim M, Kingsley CI, Bushell AR, Sawitzki BS, Wood KJ.

J Immunol. 2004 Jan 15;172(2):923-8.

7.
8.
9.

Immunoregulatory T-cells can mediate specific unresponsiveness to alloantigens in vivo.

Wood KJ, Hara M, Kingsley CI, Karim M, Bushell AR, Morris PJ.

Transplant Proc. 2001 Nov-Dec;33(7-8):3829-30. Review. No abstract available.

PMID:
11750631
10.

IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.

Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ.

J Immunol. 2001 Mar 15;166(6):3789-96.

11.

Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.

Jones ND, Turvey SE, Van Maurik A, Hara M, Kingsley CI, Smith CH, Mellor AL, Morris PJ, Wood KJ.

J Immunol. 2001 Feb 15;166(4):2824-30.

12.

Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.

Barbara JA, Turvey SE, Kingsley CI, Spriewald BM, Hara M, Witzke O, Morris PJ, Wood KJ.

Transplantation. 2000 Dec 15;70(11):1641-9.

PMID:
11152227
13.

Fas ligand-transfected myoblasts and islet cell transplantation.

Turvey SE, Gonzalez-Nicolini V, Kingsley CI, Larregina AT, Morris PJ, Castro MG, Lowenstein PR, Wood KJ.

Transplantation. 2000 May 15;69(9):1972-6.

PMID:
10830245
14.

Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.

Smith T, Hewson AK, Kingsley CI, Leonard JP, Cuzner ML.

Am J Pathol. 1997 Jun;150(6):1909-17.

Supplemental Content

Loading ...
Support Center